Dr. Mark Talary, chief technology officer of IROC Science to Innovation AG in Zürich, Switzerland, recently authored this in-depth look at the European Union's Medical Device Directives for The Ophthalmologist.
Are LASIK ablations good enough, or could they be improved by using more accurate individual-patient parameters? Arthur Cummings, MD, FRCS, believes outcomes can be made more accurate, and he notes that current ablations are based on the Gullstrand Eye model that assumes 43 D cornea and an axial length of 24 mm. “Irrespective of how sophisticated the data is that you’re going to use to drive the treatment, when you enter it into the laser, the laser thinks you are treating Gullstrand’s Eye,” Dr Cummings said.
The Centers for Advanced Orthopaedics (The Centers), the largest provider of orthopaedic and musculoskeletal care in the regions it serves, today announced an exclusive partnership with Everseat, a cutting-edge mobile platform that will increase patients’ convenient access to care.Read More
The evolution of diagnostic imaging technologies across medicine has been rapid, and a number of companies seeking approval for novel drugs and devices have been using and want to use imaging data as study endpoints in clinical trials. To assist these companies, the U.S. Food and Drug Administration (FDA) recently released a new draft guidance on the use of images in clinical trials.Read More
In an interview with MPT, Jeff Peres, Everseat CEO and Ethis HealthTech partner, discussed the mobile health revolution – and how Everseat’s technology can save valuable time for medical professionals.